Ticker
HRTXCompany Name
HERON THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 1.55M | $ 0.01 | 1 | 154.02M |
3/31/2025 | $ -5.3M | $ -0.03 | 1 | 153.49M |
12/31/2024 | $ -11.1M | $ -0.07 | 1 | 152.45M |
9/30/2024 | $ -27.46M | $ -0.18 | 1 | 152.83M |
6/30/2024 | $ -47.62M | $ -0.31 | 1 | 152.31M |
3/31/2024 | $ -80.45M | $ -0.53 | 1 | 151.2M |
12/31/2023 | $ -110.06M | $ -0.8 | 1 | 138.13M |
9/30/2023 | $ -118.87M | $ -0.82 | 1 | 144.99M |
6/30/2023 | $ -135.77M | $ -1.13 | 1 | 119.72M |
3/31/2023 | $ -150.07M | $ -1.26 | 1 | 119.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for HERON THERAPEUTICS INC is calculated as follows: EBIT [ $ -228.7M ] / (Shares WA [ 90.85M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -2.52 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.71 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.39 |
std | $ 3.41 |